Omics Technologies in Personalized Combination Therapy for Cardiovascular Diseases: Challenges and Opportunities

References

• Lauwen S , de JongEK , LefeberDJ , den HollanderAI. Omics biomarkers in ophthalmology. Investig. Ophthalmol. Vis. Sci.58(6), BIO88–BIO98 (2017).
   PubMed Web of Science ®Google Scholar
• Kitano H . Systems biology: a brief overview. Science295(5560), 1662–1664 (2002).
   PubMed Web of Science ®Google Scholar
• Yadav SP . The wholeness in suffix -omics, -omes, and the word om. J. Biomol. Tech.18(5), 277 (2007).
   PubMedGoogle Scholar
• Olivier M , AsmisR , HawkinsGA , HowardTD , CoxLA. The need for multi-omics biomarker signatures in precision medicine. Int. J. Mol. Sci.20(19), 4781 (2019).
   PubMed Web of Science ®Google Scholar
• Maggi N , GazzarataR , RuggieroC , LombardoC , GiacominiM. Cancer precision medicine today: towards omic information in healthcare systems. Tumori105(1), 38–46 (2019).
   PubMed Web of Science ®Google Scholar
• Subramanian I , VermaS , KumarS , JereA , AnamikaK. Multi-omics data integration, interpretation, and its application. Bioinform. Biol. Insights14, 7–9 (2020).
   Web of Science ®Google Scholar
• Klonoff DC . Precision medicine for managing diabetes. J. Diabetes Sci. Technol.9(1), 3–7 (2015).
   PubMedGoogle Scholar
• Schmidt MA , SchmidtCM , HubbardRM , MasonCE. Why personalized medicine is the frontier of medicine and performance for humans in space. New Sp.8(2), 63–76 (2020).
   Web of Science ®Google Scholar
• Francula-Zaninovic S , NolaIA. Management of measurable variable cardiovascular disease’ risk factors. Curr. Cardiol. Rev.14(3), 153–163 (2018).
   PubMed Web of Science ®Google Scholar
• Shantanam S . Myocardial extraction from neonatal rats. Physiol. Behav.176(1), 139–148 (2018).
   Google Scholar
• Istrail S , SuttonGG , FloreaLet al. Whole-genome shotgun assembly and comparison of human genome assemblies. Proc. Natl Acad. Sci. USA101(7), 1916–1921 (2004).
   PubMed Web of Science ®Google Scholar
• Kim DH , KimYS , SonN Il , KangCK , KimAR. Recent omics technologies and their emerging applications for personalised medicine. IET Syst. Biol.11(3), 87–98 (2017).
   PubMed Web of Science ®Google Scholar
• Sanger F , CoulsonAR. A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase. J. Mol. Biol.94(3), 441–448 (1975).
   PubMed Web of Science ®Google Scholar
• Bentley DR , BalasubramanianS , SwerdlowHPet al. Accurate whole human genome sequencing using reversible terminator chemistry. Nature456(7218), 53–59 (2008).
   PubMed Web of Science ®Google Scholar
• Li B , RuottiV , StewartRM , ThomsonJA , DeweyCN. RNA-Seq gene expression estimation with read mapping uncertainty. Bioinformatics26(4), 493–500 (2009).
   PubMed Web of Science ®Google Scholar
• Turner EH , LeeC , NgSB , NickersonDA , ShendureJ. Massively parallel exon capture and library-free resequencing across 16 genomes. Nat. Methods6(5), 315–316 (2009).
   PubMed Web of Science ®Google Scholar
• Jiang L , SchlesingerF , DavisCAet al. Synthetic spike-in standards for RNA-seq experiments. Genome Res.21(9), 1543–1551 (2011).
   PubMed Web of Science ®Google Scholar
• Nguyen CT , WeisenbergerDJ , VelicescuMet al. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2′-deoxycytidine. Cancer Res.62(22), 6456–6461 (2002).
   PubMed Web of Science ®Google Scholar
• O’Neill LP , TurnerBM. Immunoprecipitation of native chromatin: NChIP. Methods31(1), 76–82 (2003).
   PubMed Web of Science ®Google Scholar
• Wishart DS . Emerging applications of metabolomics in drug discovery and precision medicine. Nat. Rev. Drug Discov.15(7), 473–484 (2016).
   PubMed Web of Science ®Google Scholar
• Houten SM . Metabolomics: unraveling the chemical individuality of common human diseases. Ann. Med.41(6), 402–407 (2009).
   PubMed Web of Science ®Google Scholar
• Wishart DS . Applications of metabolomics in drug discovery and development. Drugs R D9(5), 307–322 (2008).
   PubMed Web of Science ®Google Scholar
• Everett JR . Pharmacometabonomics in humans: a new tool for personalized medicine. Pharmacogenomics16(7), 737–754 (2015).
   PubMed Web of Science ®Google Scholar
• Wang KC , ChangHY. Epigenomics technologies and applications. Circ. Res.122(9), 1191–1199 (2018).
   PubMed Web of Science ®Google Scholar
• Hurd PJ , NelsonCJ. Advantages of next-generation sequencing versus the microarray in epigenetic research. Briefings Funct. Genomics Proteomics8(3), 174–183 (2009).
   PubMedGoogle Scholar
• Phillips-Cremins JE , SauriaMEG , SanyalAet al. Architectural protein subclasses shape 3D organization of genomes during lineage commitment. Cell153(6), 1281–1295 (2013).
   PubMed Web of Science ®Google Scholar
• Rao SSP , HuntleyMH , DurandNCet al. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell159(7), 1665–1680 (2014).
   PubMed Web of Science ®Google Scholar
• Dixon JR , SelvarajS , YueFet al. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature485(7398), 376–380 (2012).
   PubMed Web of Science ®Google Scholar
• Kunej T . Rise of Systems Glycobiology and personalized glycomedicine: why and how to integrate glycomics with multiomics science?Omi. A J. Integr. Biol.23(12), 615–622 (2019).
   PubMed Web of Science ®Google Scholar
• Bennun SV , YaremaKJ , BetenbaughMJ , KrambeckFJ. Integration of the transcriptome and glycome for identification of glycan cell signatures. PLoS Comput. Biol.9(1), e1002813 (2013).
   PubMed Web of Science ®Google Scholar
• Reily C , StewartTJ , RenfrowMB , NovakJ. Glycosylation in health and disease. Nat. Rev. Nephrol.15(6), 346–366 (2019).
   PubMed Web of Science ®Google Scholar
• Geissner A , SeebergerPH. Glycan arrays: from basic biochemical research to bioanalytical and biomedical applications. Annu. Rev. Anal. Chem.9, 223–247 (2016).
   PubMed Web of Science ®Google Scholar
• Smith DF , CummingsRD , SongX. History and future of shotgun glycomics. Biochem. Soc. Trans.47(1), 1–11 (2019).
   PubMedGoogle Scholar
• Houle D , GovindarajuDR , OmholtS. Phenomics: the next challenge. Nat. Rev. Genet.11(12), 855–866 (2010).
   PubMed Web of Science ®Google Scholar
• Bilder RM , SabbFW , CannonTDet al. Phenomics: the systematic study of phenotypes on a genome-wide scale. Neuroscience164(1), 30–42 (2009).
   PubMed Web of Science ®Google Scholar
• Massonnet C , VileD , FabreJet al. Probing the reproducibility of leaf growth and molecular phenotypes: a comparison of three Arabidopsis accessions cultivated in ten laboratories. Plant Physiol.152(4), 2142–2157 (2010).
   PubMed Web of Science ®Google Scholar
• Cranford S , BuehlerMJ. Materiomics: biological protein materials, from nano to macro. Nanotechnol. Sci. Appl.3(1), 127–148 (2010).
   PubMedGoogle Scholar
• Cranford SW , DeBoer J , Van BlitterswijkC , BuehlerMJ. Materiomics: an -omics approach to biomaterials research. Adv. Mater.25(6), 802–824 (2013).
   PubMed Web of Science ®Google Scholar
• Leon-Mimila P , WangJ , Huertas-VazquezA. Relevance of multi-omics studies in cardiovascular diseases. Front. Cardiovasc. Med.6, 91 (2019).
   PubMed Web of Science ®Google Scholar
• Hasin Y , SeldinM , LusisA. Multi-omics approaches to disease. Genome Biol.18(1), 1–15 (2017).
   PubMedGoogle Scholar
• John A , QinB , KalariKR , WangL , YuJ. Patient-specific multi-omics models and the application in personalized combination therapy. Futur. Oncol.16(23), 1737–1750 (2020).
   PubMed Web of Science ®Google Scholar
• Cacchiarelli D , TrapnellC , ZillerMJet al. Integrative analyses of human reprogramming reveal dynamic nature of induced pluripotency. Cell162(2), 412–424 (2015).
   PubMed Web of Science ®Google Scholar
• Hu Y , AnQ , SheuK , TrejoB , FanS , GuoY. Single cell multi-omics technology: methodology and application. Front. Cell Dev. Biol.6, 28 (2018).
   PubMed Web of Science ®Google Scholar
• Peden JF , HopewellJC , SaleheenDet al. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat. Genet.43(4), 339–346 (2011).
   PubMed Web of Science ®Google Scholar
• Federico A , DiDonato I , BianchiS , DiPalma C , TagliaI , DottiMT. Hereditary cerebral small vessel diseases: a review. J. Neurol. Sci.322(1–2), 25–30 (2012).
   PubMed Web of Science ®Google Scholar
• Semsarian C , HamiltonRM. Key role of the molecular autopsy in sudden unexpected death. Hear. Rhythm9(1), 145–150 (2012).
   PubMed Web of Science ®Google Scholar
• Postma AV , BezzinaCR , ChristoffelsVM. Genetics of congenital heart disease: the contribution of the noncoding regulatory genome. J. Hum. Genet.61(1), 13–19 (2016).
   PubMed Web of Science ®Google Scholar
• Ho JE , ChenWY , ChenMHet al. Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling. J. Clin. Invest.123(10), 4208–4218 (2013).
   PubMed Web of Science ®Google Scholar
• Zampetaki A , WilleitP , TillingLet al. Prospective study on circulating microRNAs and risk of myocardial infarction. J. Am. Coll. Cardiol.60(4), 290–299 (2012).
   PubMed Web of Science ®Google Scholar
• Sühling M , WolkeC , ScharfC , LendeckelU. Proteomics and transcriptomics in atrial fibrillation. Herzschrittmacherther. Elektrophysiol.29(1), 70–75 (2018).
   PubMedGoogle Scholar
• McDonald TG , Van EykJE. Mitochondrial proteomics: undercover in the lipid bilayer. Basic Res. Cardiol.98(4), 219–227 (2003).
   PubMed Web of Science ®Google Scholar
• Mourino-Alvarez L , Baldan-MartinM , RinconRet al. Recent advances and clinical insights into the use of proteomics in the study of atherosclerosis. Expert Rev. Proteomics14(8), 701–713 (2017).
   PubMed Web of Science ®Google Scholar
• Luers C , SutcliffeA , BinderL , IrleS , PieskeB. NT-proANP and NT-proBNP as prognostic markers in patients with acute decompensated heart failure of different etiologies. Clin. Biochem.46(12), 1013–1019 (2013).
   PubMed Web of Science ®Google Scholar
• Ko D , BensonMD , NgoDet al. Proteomics profiling and risk of new-onset atrial fibrillation: framingham heart study. J. Am. Heart Assoc.8(6), e010976 (2019).
   PubMed Web of Science ®Google Scholar
• McGarrah RW , CrownSB , ZhangGF , ShahSH , NewgardCB. Cardiovascular metabolomics. Circ. Res.122(9), 1238–1258 (2018).
   PubMed Web of Science ®Google Scholar
• Chouchani ET , PellVR , GaudeEet al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature515(7527), 431–435 (2014).
   PubMed Web of Science ®Google Scholar
• Lopaschuk GD , UssherJR , FolmesCDL , JaswalJS , StanleyWC. Myocardial fatty acid metabolism in health and disease. Physiol. Rev.90(1), 207–258 (2010).
   PubMed Web of Science ®Google Scholar
• Wang TJ , LarsonMG , VasanRSet al. Metabolite profiles and the risk of developing diabetes. Nat. Med.17(4), 448–453 (2011).
   PubMed Web of Science ®Google Scholar
• Yamada Y , HoribeH , OguriMet al. Identification of novel hyper- or hypomethylated CpG sites and genes associated with atherosclerotic plaque using an epigenome -wide association study. Int. J. Mol. Med.41(5), 2724–2732 (2018).
   PubMed Web of Science ®Google Scholar
• Serra-Juhé C , CuscóI , HomsA , FloresR , ToránN , Pérez-JuradoLA. DNA methylation abnormalities in congenital heart disease. Epigenetics10(2), 167–177 (2015).
   PubMed Web of Science ®Google Scholar
• Jo BS , KohIU , BaeJBet al. Methylome analysis reveals alterations in DNA methylation in the regulatory regions of left ventricle development genes in human dilated cardiomyopathy. Genomics108(2), 84–92 (2016).
   PubMed Web of Science ®Google Scholar
• Movassagh M , ChoyMK , KnowlesDAet al. Distinct epigenomic features in end-stage failing human hearts. Circulation124(22), 2411–2422 (2011).
   PubMed Web of Science ®Google Scholar
• Maverakis E , KimK , ShimodaMet al. Glycans in the immune system and the altered glycan theory of autoimmunity: a critical review. J. Autoimmun.57, 1–13 (2015).
   PubMed Web of Science ®Google Scholar
• Malakar AK , ChoudhuryD , HalderB , PaulP , UddinA , ChakrabortyS. A review on coronary artery disease, its risk factors, and therapeutics. J. Cell. Physiol.234(10), 16812–16823 (2019).
   PubMed Web of Science ®Google Scholar
• Schildkraut JM , MyersRH , CupplesLA , KielyDK , KannelWB. Coronary risk associated with age and sex of parental heart disease in the Framingham Study. Am. J. Cardiol.64(10), 555–559 (1989).
   PubMed Web of Science ®Google Scholar
• Manace LC , GodiwalaTN , BabyatskyMW. Genomics of cardiovascular disease. Mt. Sinai J. Med.76(6), 613–623 (2009).
   PubMedGoogle Scholar
• Altshuler DL , DurbinRM , AbecasisGRet al. A map of human genome variation from population-scale sequencing. Nature467(7319), 1061–1073 (2010).
   PubMed Web of Science ®Google Scholar
• Feigin VL , KrishnamurthiRV , ParmarPet al. Update on the global burden of ischemic and hemorrhagic stroke in 1990–2013: The GBD 2013 study. Neuroepidemiology45(3), 161–176 (2015).
   PubMed Web of Science ®Google Scholar
• Alexandru R , TerecoasăEO , BăjenaruOA , TiuC. Etiologic classification of ischemic stroke: where do we stand?Clin. Neurol. Neurosurg.159, 93–106 (2017).
   PubMed Web of Science ®Google Scholar
• Kalayinia S , GoodarzynejadH , MalekiM , MahdiehN. Next generation sequencing applications for cardiovascular disease. Ann. Med.50(2), 91–109 (2018).
   PubMed Web of Science ®Google Scholar
• Kuriachan VP , SumnerGL , MitchellLB. Sudden cardiac death. Curr. Probl. Cardiol.40(4), 133–200 (2015).
   PubMed Web of Science ®Google Scholar
• Beckmann BM , WildeAAM , KääbS. Clinical utility gene card for: long-QT syndrome (types 1–13). Eur. J. Hum. Genet.21(10), 1185 (2013).
   Web of Science ®Google Scholar
• Millat G , ChanavatV , RoussonR. Evaluation of a new high-throughput next-generation sequencing method based on a custom AmpliSeq™ Library and Ion Torrent PGM™ sequencing for the rapid detection of genetic variations in long QT syndrome. Mol. Diagnosis Ther.18(5), 533–539 (2014).
   PubMed Web of Science ®Google Scholar
• Chae H , KimJ , LeeGDet al. Considerations when using next-generation sequencing for genetic diagnosis of long-QT syndrome in the clinical testing laboratory. Clin. Chim. Acta464, 128–135 (2017).
   PubMed Web of Science ®Google Scholar
• Arrington CB , BleylSB , MatsunamiNet al. Exome analysis of a family with pleiotropic congenital heart disease. Circ. Cardiovasc. Genet.5(2), 175–182 (2012).
   PubMedGoogle Scholar
• Bédard E , ShoreDF , GatzoulisMA. Adult congenital heart disease: a 2008 overview. Br. Med. Bull.85(1), 151–180 (2008).
   PubMedGoogle Scholar
• Al Turki S , ManickarajAK , MercerCLet al. Rare variants in NR2F2 cause congenital heart defects in humans. Am. J. Hum. Genet.94(4), 574–585 (2014).
   PubMed Web of Science ®Google Scholar
• Villard E , PerretC , GaryFet al. A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur. Heart J.32(9), 1065–1076 (2011).
   PubMed Web of Science ®Google Scholar
• Sadananda SN , FooJN , TohMTet al. Targeted next-generation sequencing to diagnose disorders of HDL cholesterol. J. Lipid Res.56(10), 1993–2001 (2015).
   PubMed Web of Science ®Google Scholar
• Freedman JE , IafratiHF. Use of genetics and transcriptomics in the diagnosis and treatment of coronary artery disease. Rev. Española Cardiol.63(10), 1123–1126 (2010).
   PubMed Web of Science ®Google Scholar
• Article R . Genetic changes NIH public access. Bone23(1), 1–7 (2008).
   Google Scholar
• Widera C , GiannitsisE , KempfTet al. Identification of follistatin-like 1 by expression cloning as an activator of the growth differentiation factor 15 gene and a prognostic biomarker in acute coronary syndrome. Clin. Chem.58(8), 1233–1241 (2012).
   PubMed Web of Science ®Google Scholar
• Matkovich SJ . Transcriptome analysis in heart failure. Curr. Opin. Cardiol.31(3), 242–248 (2016).
   PubMed Web of Science ®Google Scholar
• Siemelink MA , ZellerT. Biomarkers of coronary artery disease: the promise of the transcriptome. Curr. Cardiol. Rep.16(8), 513 (2014).
   PubMed Web of Science ®Google Scholar
• Deng MC , EisenHJ , MehraMRet al. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am. J. Transplant.6(1), 150–160 (2006).
   PubMed Web of Science ®Google Scholar
• Scheuermann JC , BoyerLA. Getting to the heart of the matter: long non-coding RNAs in cardiac development and disease. EMBO J.32(13), 1805–1816 (2013).
   PubMed Web of Science ®Google Scholar
• Wu B , HuangC , Kato-MaedaMet al. Messenger RNA expression of IL-8, FOXP3, and IL-12β differentiates latent tuberculosis infection from disease. J. Immunol.178(6), 3688–3694 (2007).
   PubMed Web of Science ®Google Scholar
• De Souza AI , CardinS , WaitRet al. Proteomic and metabolomic analysis of atrial profibrillatory remodelling in congestive heart failure. J. Mol. Cell. Cardiol.49(5), 851–863 (2010).
   PubMed Web of Science ®Google Scholar
• Chilukoti RK , GieseA , MalenkeWet al. Atrial fibrillation and rapid acute pacing regulate adipocyte/adipositas-related gene expression in the atria. Int. J. Cardiol.187(1), 604–613 (2015).
   PubMedGoogle Scholar
• Mokou M , LygirouV , VlahouA , MischakH. Proteomics in cardiovascular disease: recent progress and clinical implication and implementation. Expert Rev. Proteomics14(2), 117–136 (2017).
   PubMed Web of Science ®Google Scholar
• Stenemo M , NowakC , BybergLet al. Circulating proteins as predictors of incident heart failure in the elderly. Eur. J. Heart Fail.20(1), 55–62 (2018).
   PubMed Web of Science ®Google Scholar
• Israr MZ , HeaneyLM , SuzukiT. Proteomic biomarkers of heart failure. Heart Fail. Clin.14(1), 93–107 (2018).
   PubMed Web of Science ®Google Scholar
• Mayr M , YusufS , WeirGet al. Combined metabolomic and proteomic analysis of human atrial fibrillation. J. Am. Coll. Cardiol.51(5), 585–594 (2008).
   PubMed Web of Science ®Google Scholar
• Barallobre-Barreiro J , GuptaSK , ZoccaratoAet al. Glycoproteomics reveals decorin peptides with anti-myostatin activity in human atrial fibrillation. Circulation134(11), 817–832 (2016).
   PubMed Web of Science ®Google Scholar
• Chiang DY , HeckAJR , DobrevD , WehrensXHT. Regulating the regulator: insights into the cardiac protein phosphatase 1 interactome. J. Mol. Cell. Cardiol.101, 165–172 (2016).
   PubMed Web of Science ®Google Scholar
• Lepedda AJ , CiglianoA , CherchiGMet al. A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. Atherosclerosis203(1), 112–118 (2009).
   PubMed Web of Science ®Google Scholar
• Iida M , HaradaS , TakebayashiT. Application of metabolomics to epidemiological studies of atherosclerosis and cardiovascular disease. J. Atheroscler. Thromb.26(9), 747–757 (2019).
   PubMed Web of Science ®Google Scholar
• Pascual F , ColemanRA. Fuel availability and fate in cardiac metabolism: a tale of two substrates. Biochim. Biophys. Acta1861(10), 1425–1433 (2016).
   PubMed Web of Science ®Google Scholar
• Lusis AJ , MarR , PajukantaP. Genetics of atherosclerosis. Annu. Rev. Genomics Hum. Genet.5(Mi), 189–218 (2004).
   PubMedGoogle Scholar
• van der Harst P , de WindtLJ , ChambersJC. Translational perspective on epigenetics in cardiovascular disease. J. Am. Coll. Cardiol.70(5), 590–606 (2017).
   PubMed Web of Science ®Google Scholar
• Wechsler H , LevineS , IdelsonRK , RohmanM , TaylorJO. The physician’s role in health promotion–a survey of primary-care practitioners. N. Engl. J. Med.308(2), 97–100 (1983).
   PubMed Web of Science ®Google Scholar
• Ma Y , OrdovasJM. The integration of epigenetics and genetics in nutrition research for CVD risk factors. Proc. Nutr. Soc.76(3), 333–346 (2017).
   PubMed Web of Science ®Google Scholar
• Muka T , KoromaniF , PortillaEet al. The role of epigenetic modifications in cardiovascular disease: a systematic review. Int. J. Cardiol.212, 174–183 (2016).
   PubMed Web of Science ®Google Scholar
• Lawler PR . Glycomics and cardiovascular disease: advancing down the path towards precision. Circ. Res.122(11), 1488–1490 (2018).
   PubMed Web of Science ®Google Scholar